Ascendis Pharma A (ASND) EPS (Diluted) (2014 - 2026)

Ascendis Pharma A (ASND) EPS (Diluted) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 0.00
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.15
4 NuCana 279.75 Bn 279.75 Bn - -368,323.02
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 6.75
7 Belite Bio 62.51 Bn 62.51 Bn - 0.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 7.33
9 Revolution Medicines 37.78 Bn 37.78 Bn - -2.29
10 Ascendis Pharma A 15.31 Bn 14.64 Bn 268.20 Mn 11.47

Historic Data

Download Data
DateValue
Mar 31, 2026 11.47
Dec 31, 2025 -0.65
Sep 30, 2025 -1.20
Jun 30, 2025 -0.71
Mar 31, 2025 -1.66
Dec 31, 2024 -0.71
Sep 30, 2024 -1.89
Jun 30, 2024 1.94
Mar 31, 2024 3.42
Dec 31, 2023 -2.28
Sep 30, 2023 -4.24
Jun 30, 2023 3.20
Mar 31, 2023 -2.88
Dec 31, 2022 -5.08
Sep 30, 2022 -4.14
Jun 30, 2022 -2.10
Mar 31, 2022 -3.38
Dec 31, 2021 -2.91
Sep 30, 2021 2.27
Jun 30, 2021 3.89